ZEPP Earnings & Financial Statements
Zepp Health Corporation
$3.72
-$0.12(-3.12%)
36
Overall
60
Value
18
Tech
31
Quality
Market Cap
$56.31M
Volume
9.65K
52W Range
$3.78 - $61.85
Target Price
$53.01
ZEPP earnings and financial statements: Zepp Health Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
ZEPP Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $258.90M | $182.60M | $352.86M | $4.14B | $6.25B |
| Cost of revenue | $159.71M | $112.37M | $260.50M | $3.34B | $4.94B |
| Operating income | -$29.23M | -$47.25M | -$30.45M | $3.48B | $5.28B |
| EBITDA | -$25.23M | -$46.02M | -$20.19M | -$256.91M | $203.44M |
| Net income | -$40.07M | -$74.42M | -$38.11M | -$288.31M | $137.80M |
| EPS (diluted) | $-2.56 | $-4.64 | $-2.05 | $-18.72 | $8.32 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $564.84M | $528.59M | $635.52M | $5.27B | $6.09B |
| Total liabilities | $350.30M | $275.87M | $282.77M | $2.58B | $3.15B |
| Shareholders’ equity | $214.53M | $251.59M | $350.88M | $2.67B | $2.92B |
| Cash and equivalents | $57.05M | $91.07M | $133.67M | $886.63M | $1.51B |
| Long-term debt | $60.58M | $77.25M | $123.22M | $715.90M | $797.97M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$25.69M | -$24.39M | $42.60M | -$787.64M | -$36.47M |
| Capital expenditure | - | - | - | -$1.44M | -$7.93M |
| Free cash flow | -$26.48M | -$25.88M | $40.92M | -$115.64M | -$44.41M |
| Dividends paid | - | - | - | $5.80M | - |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZEPP | $3.72 | -3.1% | 9.65K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |